Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Young Kwon. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Young Kwon har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ADMA / ADMA Biologics, Inc. | Director | 252 330 |
Chief Financial & Bus. Officer | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Young Kwon. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ADMA / ADMA Biologics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ADMA / ADMA Biologics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ADMA / ADMA Biologics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-23 | ADMA | KWON YOUNG | 60 000 | 18,2600 | 60 000 | 18,2600 | 1 095 600 | 186 | 15.4400 | −169 200 | −15,44 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Young Kwon som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-21 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
A - Award | −10 889 | 252 330 | −4,14 | ||||
2024-08-27 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
S - Sale | −60 000 | 241 441 | −19,90 | 18,26 | −1 095 600 | 4 408 713 | |
2024-02-28 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
A - Award | 24 040 | 301 441 | 8,67 | ||||
2023-08-24 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
P - Purchase | 25 000 | 277 401 | 9,90 | 3,90 | 97 500 | 1 081 864 | |
2023-03-08 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
A - Award | 25 815 | 252 401 | 11,39 | ||||
2022-03-09 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Employee Stock Option (right to buy) |
A - Award | 53 172 | 53 172 | |||||
2022-03-09 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
A - Award | 26 586 | 226 586 | 13,29 | ||||
2021-10-26 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
P - Purchase | 100 000 | 200 000 | 100,00 | 1,00 | 100 000 | 200 000 | |
2021-10-18 | 3 | ADMA |
ADMA BIOLOGICS, INC.
Common Stock |
100 000 | ||||||||
2021-10-18 |
|
4 | ADMA |
ADMA BIOLOGICS, INC.
Stock Option (right to buy) |
A - Award | 93 500 | 93 500 | |||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −96 863 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −115 656 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −38 334 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −35 437 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 786 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −13 013 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −1 356 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 228 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −8 502 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 137 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −19 344 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 766 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −2 363 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 214 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 712 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 466 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 572 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −50 000 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Unit |
D - Sale to Issuer | −31 500 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −2 819 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Unit |
D - Sale to Issuer | −45 000 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −160 633 | 0 | −100,00 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −652 | 160 633 | −0,40 | 32,36 | −21 099 | 5 198 084 |
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 410 | 2 819 | −33,34 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 410 | 161 285 | 0,88 | ||||
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 561 | 159 875 | −0,97 | 33,95 | −52 996 | 5 427 756 |
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 500 | 31 500 | −10,00 | ||||
2020-07-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 500 | 161 436 | 2,22 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 810 | 157 936 | −4,13 | 35,11 | −239 099 | 5 545 133 |
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 15 000 | 45 000 | 50,00 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 15 000 | 164 746 | 10,02 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 756 | 149 746 | −4,32 | 30,15 | −203 693 | 4 514 842 |
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 15 000 | 30 000 | 100,00 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 15 000 | 156 502 | 10,60 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −629 | 141 502 | −0,44 | 33,30 | −20 946 | 4 712 017 |
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 409 | 4 229 | −24,99 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 409 | 142 131 | 1,00 | ||||
2020-04-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 614 | 140 722 | −1,13 | 28,97 | −46 758 | 4 076 716 |
2020-04-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 500 | 35 000 | −9,09 | ||||
2020-04-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 500 | 142 336 | 2,52 | ||||
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 356 | 138 836 | −5,03 | 28,96 | −213 030 | 4 020 691 |
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 15 000 | 15 000 | |||||
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 15 000 | 146 192 | 11,43 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 016 | 130 103 | −6,48 | 30,03 | −270 750 | 3 906 993 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −27 500 | 0 | −100,00 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 27 500 | 139 119 | 24,64 | ||||
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −350 | 111 619 | −0,31 | 32,23 | −11 280 | 3 597 480 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −408 | 111 969 | −0,36 | 31,50 | −12 852 | 3 527 024 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 50 000 | 50 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 409 | 5 638 | −19,99 | ||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 409 | 112 377 | 1,27 | ||||
2020-01-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 235 | 110 968 | −1,10 | 30,08 | −37 149 | 3 337 917 |
2020-01-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −3 500 | 38 500 | −8,33 | ||||
2020-01-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 500 | 112 203 | 3,22 | ||||
2019-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −529 | 108 703 | −0,48 | 16,18 | −8 559 | 1 758 815 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −632 | 109 232 | −0,58 | 16,06 | −10 150 | 1 754 266 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 410 | 7 047 | −16,67 | ||||
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 410 | 109 864 | 1,30 | ||||
2019-10-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 365 | 108 454 | −5,54 | 13,83 | −88 028 | 1 499 919 |
2019-10-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −14 000 | 42 000 | −25,00 | ||||
2019-10-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 000 | 114 819 | 13,89 | ||||
2019-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −533 | 100 819 | −0,53 | 11,64 | −6 204 | 1 173 533 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −626 | 101 362 | −0,61 | 11,82 | −7 399 | 1 198 099 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | 1 409 | 8 457 | 19,99 | ||||
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 409 | 101 988 | 1,40 | ||||
2019-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | 2 998 | 0 | −100,00 | ||||
2019-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 998 | 99 518 | 3,11 | 13,26 | 39 753 | 1 319 609 | |
2019-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −354 | 96 520 | −0,37 | 14,00 | −4 956 | 1 351 280 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −419 | 96 874 | −0,43 | 13,68 | −5 732 | 1 325 236 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 410 | 9 866 | −12,50 | ||||
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 410 | 97 293 | 1,47 | ||||
2019-04-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −30 000 | 95 883 | −23,83 | ||||
2019-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −351 | 125 883 | −0,28 | 14,05 | −4 932 | 1 768 656 |
2019-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 450 | 126 234 | −3,41 | 13,10 | −58 295 | 1 653 665 |
2019-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 358 | 130 684 | −6,01 | 12,70 | −106 147 | 1 659 687 |
2019-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −27 500 | 27 500 | −50,00 | ||||
2019-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 27 500 | 139 042 | 24,65 | ||||
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −414 | 111 542 | −0,37 | 12,77 | −5 287 | 1 424 391 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 135 000 | 135 000 | |||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −494 | 111 956 | −0,44 | 11,52 | −5 691 | 1 289 733 |
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 409 | 11 276 | −11,11 | ||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 409 | 112 450 | 1,27 | ||||
2018-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −535 | 111 041 | −0,48 | 12,30 | −6 580 | 1 365 804 |
2018-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −530 | 111 576 | −0,47 | 13,15 | −6 970 | 1 467 224 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 409 | 12 685 | −10,00 | ||||
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −646 | 112 106 | −0,57 | 14,09 | −9 102 | 1 579 574 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 409 | 112 752 | 1,27 | ||||
2018-10-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 56 000 | 56 000 | |||||
2018-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −528 | 111 343 | −0,47 | 27,25 | −14 388 | 3 034 097 |
2018-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −531 | 111 871 | −0,47 | 25,70 | −13 647 | 2 875 085 |
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 410 | 14 094 | −9,09 | ||||
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −632 | 112 402 | −0,56 | 29,00 | −18 328 | 3 259 658 |
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 410 | 113 034 | 1,26 | ||||
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −4 000 | 10 000 | −28,57 | |||
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 500 | 19 725 | −11,25 | |||
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −9 164 | 4 822 | −65,52 | |||
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −8 500 | 0 | −100,00 | |||
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −8 000 | 11 500 | −41,03 | |||
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 111 624 | −2,62 | 28,90 | −86 700 | 3 225 934 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 114 624 | −3,37 | 29,40 | −117 600 | 3 369 946 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 118 624 | 3,49 | 21,56 | 86 240 | 2 557 533 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 114 624 | −2,13 | 29,30 | −73 250 | 3 358 483 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 500 | 117 124 | 2,18 | 13,02 | 32 550 | 1 524 954 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 164 | 114 624 | −7,40 | 29,46 | −269 971 | 3 376 823 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 164 | 123 788 | 7,99 | 17,96 | 164 585 | 2 223 232 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 500 | 114 624 | −6,90 | 29,43 | −250 155 | 3 373 384 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 500 | 123 124 | 7,42 | 15,44 | 131 240 | 1 901 035 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 000 | 114 624 | −6,52 | 29,21 | −233 680 | 3 348 167 |
2018-07-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 000 | 122 624 | 6,98 | 13,26 | 106 080 | 1 625 994 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −4 000 | 14 000 | −22,22 | |||
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −3 500 | 22 225 | −13,61 | |||
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −6 000 | 13 986 | −30,02 | |||
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −6 000 | 13 986 | −30,02 | |||
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −8 000 | 8 500 | −48,48 | |||
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −11 000 | 19 500 | −36,07 | |||
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 000 | 114 624 | −8,76 | 27,35 | −300 850 | 3 134 966 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 125 624 | −3,09 | 27,40 | −109 600 | 3 442 098 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 129 624 | 3,18 | 21,56 | 86 240 | 2 794 693 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 500 | 125 624 | −2,71 | 27,33 | −95 655 | 3 433 304 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 129 124 | 2,79 | 13,02 | 45 570 | 1 681 194 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 125 624 | −4,56 | 27,48 | −164 880 | 3 452 148 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 131 624 | 4,78 | 17,96 | 107 760 | 2 363 967 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 125 624 | −4,56 | 27,40 | −164 400 | 3 442 098 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 131 624 | 4,78 | 12,58 | 75 480 | 1 655 830 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 000 | 125 624 | −5,99 | 27,40 | −219 200 | 3 442 098 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 000 | 133 624 | 6,37 | 15,44 | 123 520 | 2 063 155 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 000 | 125 624 | −8,05 | 27,40 | −301 400 | 3 442 098 |
2018-07-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 000 | 136 624 | 8,76 | 13,26 | 145 860 | 1 811 634 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 18 000 | −10,00 | |||
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −4 000 | 25 725 | −13,46 | |||
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −6 000 | 19 986 | −23,09 | |||
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −6 000 | 19 986 | −23,09 | |||
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −5 500 | 16 500 | −25,00 | |||
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −11 000 | 30 500 | −26,51 | |||
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 999 | 125 624 | −8,72 | 25,40 | −304 775 | 3 190 850 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 137 623 | −1,43 | 25,91 | −51 820 | 3 565 812 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 139 623 | 1,45 | 21,56 | 43 120 | 3 010 272 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 137 623 | −2,82 | 25,41 | −101 640 | 3 497 000 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 141 623 | 2,91 | 13,02 | 52 080 | 1 843 931 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 137 623 | −4,18 | 25,41 | −152 460 | 3 497 000 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 137 623 | −4,18 | 25,41 | −152 460 | 3 497 000 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 143 623 | 4,36 | 17,96 | 107 760 | 2 579 469 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 143 623 | 4,36 | 12,58 | 75 480 | 1 806 777 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 500 | 137 623 | −3,84 | 25,54 | −140 470 | 3 514 891 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 500 | 143 123 | 4,00 | 15,44 | 84 920 | 2 209 819 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 000 | 137 623 | −7,40 | 25,40 | −279 400 | 3 495 624 |
2018-07-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 11 000 | 148 623 | 7,99 | 13,26 | 145 860 | 1 970 741 |
2018-06-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 | 137 623 | 0,00 | 24,90 | −25 | 3 426 813 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 29 725 | −6,30 | |||
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 29 725 | −6,30 | |||
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −3 000 | 25 986 | −10,35 | |||
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 22 800 | −8,06 | |||
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −5 500 | 41 500 | −11,70 | |||
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 137 624 | −1,43 | 23,90 | −47 800 | 3 289 214 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 137 624 | −1,43 | 23,90 | −47 800 | 3 289 214 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 137 624 | −1,43 | 23,90 | −47 800 | 3 289 214 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −227 | 139 624 | −0,16 | 23,90 | −5 425 | 3 337 014 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −773 | 139 851 | −0,55 | 23,90 | −18 475 | 3 342 439 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 140 624 | −1,40 | 23,90 | −47 800 | 3 360 914 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 142 624 | 1,42 | 13,02 | 26 040 | 1 856 964 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 140 624 | −2,09 | 23,90 | −71 700 | 3 360 914 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 143 624 | 2,13 | 17,96 | 53 880 | 2 579 487 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 142 624 | 1,42 | 12,58 | 25 160 | 1 794 210 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 142 624 | 1,42 | 15,44 | 30 880 | 2 202 115 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 500 | 140 624 | −3,76 | 23,90 | −131 450 | 3 360 914 |
2018-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 500 | 146 124 | 3,91 | 13,26 | 72 930 | 1 937 604 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −351 | 140 624 | −0,25 | 23,40 | −8 213 | 3 290 602 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 31 725 | −5,93 | |||
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 31 725 | −5,93 | |||
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −3 000 | 28 986 | −9,38 | |||
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 24 800 | −7,46 | |||
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −5 000 | 47 000 | −9,62 | |||
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −213 | 140 975 | −0,15 | 22,90 | −4 878 | 3 228 328 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −787 | 141 188 | −0,55 | 22,90 | −18 022 | 3 233 205 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 141 975 | −1,39 | 22,90 | −45 800 | 3 251 228 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 141 975 | −1,39 | 22,90 | −45 800 | 3 251 228 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 141 975 | −1,39 | 22,90 | −45 800 | 3 251 228 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 143 975 | 1,41 | 13,02 | 26 040 | 1 874 554 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 141 975 | −2,07 | 22,90 | −68 700 | 3 251 228 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 144 975 | 2,11 | 17,96 | 53 880 | 2 603 751 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 143 975 | 1,41 | 12,58 | 25 160 | 1 811 206 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 143 975 | 1,41 | 15,44 | 30 880 | 2 222 974 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 141 975 | −3,40 | 22,90 | −114 500 | 3 251 228 |
2018-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 146 975 | 3,52 | 13,26 | 66 300 | 1 948 888 |
2018-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −352 | 141 975 | −0,25 | 21,95 | −7 726 | 3 116 351 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 33 725 | −5,60 | |||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 33 725 | −5,60 | |||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −3 000 | 31 986 | −8,57 | |||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 26 800 | −6,94 | |||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −5 000 | 52 000 | −8,77 | |||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −204 | 142 327 | −0,14 | 21,90 | −4 468 | 3 116 961 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −296 | 142 531 | −0,21 | 21,90 | −6 482 | 3 121 429 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 142 827 | −1,38 | 21,90 | −43 800 | 3 127 911 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 142 827 | −1,38 | 21,90 | −43 800 | 3 127 911 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 142 827 | −1,38 | 21,90 | −43 800 | 3 127 911 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 144 827 | 1,40 | 13,02 | 26 040 | 1 885 648 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 142 827 | −2,06 | 21,90 | −65 700 | 3 127 911 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 145 827 | 2,10 | 17,96 | 53 880 | 2 619 053 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 144 827 | 1,40 | 12,58 | 25 160 | 1 821 924 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 144 827 | 1,40 | 15,44 | 30 880 | 2 236 129 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 142 827 | −3,38 | 21,90 | −109 500 | 3 127 911 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 147 827 | 3,50 | 13,26 | 66 300 | 1 960 186 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 409 | 15 504 | −8,33 | ||||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −493 | 142 827 | −0,34 | 18,08 | −8 913 | 2 582 312 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 409 | 143 320 | 0,99 | ||||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 35 725 | −5,30 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 35 725 | −5,30 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −3 589 | 34 986 | −9,30 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −2 000 | 28 800 | −6,49 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option(Right to Buy) |
M - Exercise | X | −5 000 | 57 000 | −8,06 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 141 911 | −0,35 | 20,90 | −10 450 | 2 965 940 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 142 411 | −1,38 | 20,90 | −41 800 | 2 976 390 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 142 411 | −1,38 | 20,90 | −41 800 | 2 976 390 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 142 411 | −1,38 | 20,90 | −41 800 | 2 976 390 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 144 411 | 1,40 | 13,02 | 26 040 | 1 880 231 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 589 | 142 411 | −2,46 | 20,90 | −75 010 | 2 976 390 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 589 | 146 000 | 2,52 | 17,96 | 64 458 | 2 622 160 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 144 411 | 1,40 | 12,58 | 25 160 | 1 816 690 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 144 411 | 1,40 | 15,44 | 30 880 | 2 229 706 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 142 411 | −3,39 | 20,90 | −104 500 | 2 976 390 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 147 411 | 3,51 | 13,26 | 66 300 | 1 954 670 |
2018-03-12 | 3 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
284 822 | ||||||||
2018-03-12 | 3 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
284 822 |